Press Releases iTeos Therapeutics, Inc.

Equities

ITOS

US46565G1040

Delayed Nasdaq Other stock markets 01:22:16 14/05/2024 am IST			5-day change	1st Jan Change
17 ^USD	-2.52%		+36.54%	+54.75%

02:31pm	HC Wainwright Adjusts Price Target on iTeos Therapeutics to $46 From $44, Maintains Buy Rating	MT
10/05	Wedbush Adjusts iTeos Therapeutics' Price Target to $21 From $18, Maintains Outperform Rating	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ITeos Therapeutics Announces $120 Million Registered Direct Offering	08:54pm	AQ
ITeos Reports First Quarter 2024 Financial Results and Provides Business Updates	08:54pm	AQ
ITeos Therapeutics : SECURITIES PURCHASE AGREEMENT - Form 8-K	04:34pm	PU
ITeos Reports First Quarter 2024 Financial Results and Provides Business Updates	10/05	GL
ITeos Therapeutics Announces $120 Million Registered Direct Offering	10/05	GL
ITeos Therapeutics Announces $120 Million Registered Direct Offering	10/05	AQ
ITeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024	08/04	AQ
ITeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024	08/04	GL
ITeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	06/03	GL
ITeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors	06/03	GL
ITeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	06/03	AQ
ITeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors	06/03	AQ
ITeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024	06/03	GL
ITeos to Participate in Upcoming Investor Conferences	01/03	GL
ITeos Announces 2024 Strategic Priorities and Anticipated Milestones	08/01	GL
ITeos Announces 2024 Strategic Priorities and Anticipated Milestones	08/01	AQ
NiKang Therapeutics Appoints Joanne Lager, M.D., as Chief Medical Officer	05/01	AQ
ITeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03/01	AQ
ITeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03/01	GL
ITeos to Present at the Piper Sandler 35th Annual Healthcare Conference	21/11	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases iTeos Therapeutics, Inc.

Equities

ITOS

US46565G1040

Press Releases

Filters